Sanofi (SNY) Earnings Call Analysis
NASDAQ · Unknown · Unknown
Earnings Reports
-
Sanofi (SNY) Q2 2026: Launch Portfolio Grows 60%, Elevating 2030 Sales Ambition
July 30, 2026
-
Sanofi (SNY) Q3 2025: New Launches Drive 41% Sales Surge, Offsetting Vaccine Headwinds
June 16, 2026
-
Sanofi (SNY) Q1 2026: Launch Portfolio Grows 44% as Rare Disease and Immunology Drive Strategic Repositioning
April 23, 2026
-
SNY Q4 2025: New Product Sales Jump 34%, Signaling Pipeline-Driven Growth Trajectory
January 29, 2026